PBYI Q2 2017 Earnings — Puma Biotechnology, Inc. Revenue & Financial Results | Market Cap Arena

PBYIPuma Biotechnology, Inc.

$299M

Q2 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$78M

Net Income

-$78M

EPS (Diluted)

$-2.10

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$46M

Free Cash Flow

-$46M

Stock-Based Comp.

$27M

Balance Sheet

Total Assets

$173M

Total Liabilities

$53M

Stockholders' Equity

$120M

Cash & Equivalents

$81M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$78M	-$66M	-17.6%
Net Income	-$78M	-$67M	-16.9%